Med-Tech Innovation August 23, 2021
Paul Chaffin

Paul Chaffin, senior vice president, president medical and pharma solutions division at Molex, discusses the importance of a robust supply chain, while highlighting the impact of COVID-19.

COVID’s public health impact has reached into global supply chains across a broad swathe of market sectors, making it one of the defining stories of the last year for manufacturing.

In recent weeks, we’ve seen how the pandemic has played a key part in the global shortage of semiconductors. Because of the vital role that these electronic components play in every part of our lives, this so-called “chip crunch” has heavily weighed down output forecasts for everything from automotive manufacture to domestic appliances, and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health IT, Medical Devices, Supply Chain, Technology
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article